Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Titel:
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Auteur:
Weber, Jeffrey S D'Angelo, Sandra P Minor, David Hodi, F Stephen Gutzmer, Ralf Neyns, Bart Hoeller, Christoph Khushalani, Nikhil I Miller Jr, Wilson H Lao, Christopher D Linette, Gerald P Thomas, Luc Lorigan, Paul Grossmann, Kenneth F Hassel, Jessica C Maio, Michele Sznol, Mario Ascierto, Paolo A Mohr, Peter Chmielowski, Bartosz Bryce, Alan Svane, Inge M Grob, Jean-Jacques Krackhardt, Angela M Horak, Christine Lambert, Alexandre Yang, Arvin S Larkin, James